Herbalife Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Herbalife de 15.8% y 3.2% por año respectivamente. Se prevé que el BPA crezca en un 13.7% al año. Se espera que la rentabilidad financiera sea de 1731.4% en 3 años.
Información clave
15.8%
Tasa de crecimiento de los beneficios
13.69%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Personal Products | 33.1% |
| Tasa de crecimiento de los ingresos | 3.2% |
| Rentabilidad financiera futura | 1,731.39% |
| Cobertura de analistas | Low |
| Última actualización | 13 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Artículo de análisis • May 19
Investors Can Find Comfort In Herbalife's (NYSE:HLF) Earnings Quality
Investors were disappointed with the weak earnings posted by Herbalife Ltd. ( NYSE:HLF ). However, our analysis...Seeking Alpha • May 11
Herbalife: The Stock Wall Street Loves To Hate Is Making A Comeback
Summary Herbalife is undergoing a significant transformation, shifting from its traditional multi-level marketing model to a modern health and wellness brand. HLF is leveraging biomarker-driven personalization, direct digital health engagement, and strategic acquisitions like Bioniq and Pro2col to diversify its offerings. Recent debt refinancing and ongoing reductions have improved HLF's financial profile, with debt falling from ~$3.0B in 2021 to ~$2.18B in 2025. Wall Street has largely discounted HLF's transformation, overlooking its established brand, cash flow, and loyal customer base supporting its strategic pivot. Read the full article on Seeking Alpha
Actualización de narrativa • May 05
HLF: Mixed 2026 Guidance And Execution Outlook Will Shape Turnaround Prospects
Herbalife's analyst price target has been revised higher to $17.50 from $16.50, with analysts pointing to updated fair value assumptions and recent target increases at firms such as Citi, BofA and Mizuho following Q4 results and 2026 guidance. Analyst Commentary Recent research updates show a mix of optimism and caution around Herbalife, with price targets moving in different directions as analysts react to Q4 results, 2026 guidance and updated assumptions around execution and valuation.
Actualización de narrativa • Apr 20
HLF: 2026 Guidance And Margin Recovery Will Drive Turnaround Momentum
Analysts lifted their price targets for Herbalife by as much as $4, with some pointing to Q4 results that were largely in line, fresh 2026 guidance, and what they view as stronger recent momentum as key factors behind the adjustment. Analyst Commentary Bullish analysts are highlighting recent price target increases on Herbalife as a sign of improving confidence in the story, especially after Q4 results that were described as largely in line and supported by new 2026 guidance.Actualización de narrativa • Apr 06
HLF: Turnaround Momentum And Q1 2026 Outlook Will Support Margin Recovery
Herbalife's updated analyst price target has moved from $14.00 to $16.50 as analysts factor in recent target increases, slightly higher projected revenue growth and margins, and a modestly lower discount rate, alongside updated views on valuation multiples. Analyst Commentary Recent research views on Herbalife show a mix of optimism about a potential turnaround and caution about the broader sector and the company’s fundamentals.
Actualización de narrativa • Mar 23
HLF: 2026 Turnaround Ambitions Will Face Ongoing Competitive And Fundamental Pressures
Herbalife's analyst price target has shifted toward $9.00, with recent research citing Q4 results viewed as solid by some firms, new 2026 guidance, and mixed views on valuation and competitive pressures. Some analysts also commented that regulatory concerns in the U.S. are considered resolved and the business model more sustainable.Actualización de narrativa • Mar 09
HLF: 2026 Turnaround Hopes Will Confront Persistent Competitive And Fundamental Risks
The analyst price target for Herbalife has been raised by $1 to $9. Analysts point to largely in line Q4 results, new 2026 guidance, and a mix of Buy, Neutral, and Underperform views that reflect both perceived momentum and ongoing concerns around competition, fundamentals, and valuation.Actualización de narrativa • Feb 23
HLF: Turnaround Will Be Driven By 2026 Guidance And Margin Recovery
Narrative Update: Herbalife The updated analyst fair value estimate for Herbalife has moved from $11 to $25, a shift analysts link to refreshed price targets in the $9 to $21 range, stronger Q4 commentary, improved margin assumptions, and a lower discount rate despite mixed views on long term growth and valuation risks. Analyst Commentary Recent Street research on Herbalife reflects a mix of views, but several bullish analysts have been willing to raise price targets or upgrade their stance following recent updates from the company.Actualización de narrativa • Feb 08
HLF: Turnaround Hopes Under New Leadership Will Confront Compressed Sector Multiples
Narrative Update: Herbalife Analyst Price Target Move The blended analyst price target for Herbalife has moved higher, with recent increases such as Mizuho's lift to $13 and Maxim's initiation at $20. Analysts point to an ongoing turnaround, progress under new leadership, and a healthier long term profile for Herbalife's business model, while also noting continuing concerns about competition and broader macro uncertainty.Actualización de narrativa • Jan 25
HLF: Recovery Story Under New Leadership Will Face Compressed Sector Multiples
Narrative Update on Herbalife The analyst price target for Herbalife has been revised higher to reflect an updated fair value of $8.00, a lower discount rate of 10.02%, and adjustments to revenue growth, profit margin, and future P/E assumptions, as analysts factor in recent target hikes, Buy initiations, and views of a continuing recovery path under new leadership. Analyst Commentary Recent Street research on Herbalife reflects a mix of optimism about a potential recovery and caution around execution and valuation risks.Artículo de análisis • Jan 22
Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
Herbalife Ltd. ( NYSE:HLF ) shares have continued their recent momentum with a 27% gain in the last month alone. The...Actualización de narrativa • Jan 11
HLF: Turnaround And Margin Recovery Under New Leadership Will Face Valuation Constraints
The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations. Analyst Commentary Recent research on Herbalife reflects a mix of optimism about the company’s turnaround efforts and caution about broader sector and macro headwinds.Actualización de narrativa • Dec 25
HLF: Recovery Path Under New Leadership Will Likely Deliver Disappointing Multiple Expansion
Analysts have modestly raised their fair value estimate for Herbalife from approximately $9.67 to $12.00 per share, citing a lower perceived risk profile, steady growth and margin assumptions, and a more constructive view on future earnings multiples as fundamentals continue on a recovery path under new leadership. Analyst Commentary Analyst sentiment around Herbalife is gradually improving as execution under new leadership gains traction and forward growth expectations firm up, though views on the pace and durability of the recovery remain mixed.Actualización de narrativa • Dec 11
HLF: Recovery Path Under New Leadership Will Likely Prove Overpriced
Analysts have modestly raised their price target on Herbalife to $11 from $10, citing a gradually lower perceived risk profile, steady long term growth and margin assumptions, and growing confidence that the company is on a recovery path under new leadership, with a potential return to volume growth by fiscal 2026. Analyst Commentary Bullish analysts point to the recent rating upgrade and price target increase as evidence that sentiment around Herbalife is gradually improving, with expectations that operational execution will support a more favorable risk and reward profile over the next several years.Actualización de narrativa • Nov 27
HLF: Uncertainty Around CEO Transition Will Challenge Near-Term Momentum
Herbalife’s analyst price target has been raised to $11 from $10, as analysts point to recovering fundamentals and the company’s strategic leadership changes as promising signs for future growth. Analyst Commentary Analysts have recently weighed in on Herbalife, offering a mix of optimism about its improving fundamentals and some caution about ongoing risks.Artículo de análisis • Nov 13
We Think That There Are Some Issues For Herbalife (NYSE:HLF) Beyond Its Promising Earnings
The market for Herbalife Ltd.'s ( NYSE:HLF ) stock was strong after it released a healthy earnings report last week...Artículo de análisis • Oct 29
The Market Doesn't Like What It Sees From Herbalife Ltd.'s (NYSE:HLF) Earnings Yet
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Artículo de análisis • Sep 26
At US$8.75, Is Herbalife Ltd. (NYSE:HLF) Worth Looking At Closely?
Herbalife Ltd. ( NYSE:HLF ), might not be a large cap stock, but it saw a decent share price growth of 11% on the NYSE...Artículo de análisis • Jul 24
A Look At The Intrinsic Value Of Herbalife Ltd. (NYSE:HLF)
Key Insights The projected fair value for Herbalife is US$9.20 based on 2 Stage Free Cash Flow to Equity Herbalife's...Artículo de análisis • Jun 25
There's No Escaping Herbalife Ltd.'s (NYSE:HLF) Muted Earnings Despite A 26% Share Price Rise
Those holding Herbalife Ltd. ( NYSE:HLF ) shares would be relieved that the share price has rebounded 26% in the last...Artículo de análisis • May 28
Herbalife (NYSE:HLF) Hasn't Managed To Accelerate Its Returns
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Artículo de análisis • May 08
Herbalife's (NYSE:HLF) Earnings Offer More Than Meets The Eye
Herbalife Ltd.'s ( NYSE:HLF ) solid earnings announcement recently didn't do much to the stock price. We did some...Artículo de análisis • Mar 13
Herbalife Ltd.'s (NYSE:HLF) Share Price Boosted 63% But Its Business Prospects Need A Lift Too
Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 63% after a shaky period beforehand. But...Seeking Alpha • Feb 24
Herbalife: The Battleground Stock Is Showing Some Turnaround Potential
Summary Herbalife still operates in 95 countries using a direct selling and MLM model with six million independent distributors. Currently, HLF is facing declining sales volumes, which have been partly offset by price increases. However, it remains uncertain how sustainable this is in the long run. Post-FTC settlement, I think HLF has “sanitized” its business model, even though it has indeed made it more challenging to grow its MLM business. The good news is its focus. They have a mixed regional performance, in particular with China struggling while Asia Pacific stabilizes. Additionally, its recruitment and sales leaders numbers have been encouraging in Q4 and 2024. Based on EV/EBITDA metrics, HLF is undeniably still priced at a steep discount. However, at this point, I believe the risk-reward equation is more favorable for the bulls. Hence, I rate it a speculative “Buy” for the short term. Read the full article on Seeking AlphaArtículo de análisis • Feb 19
Is It Time To Consider Buying Herbalife Ltd. (NYSE:HLF)?
While Herbalife Ltd. ( NYSE:HLF ) might not have the largest market cap around , it saw a double-digit share price rise...Artículo de análisis • Jan 29
Returns At Herbalife (NYSE:HLF) Appear To Be Weighed Down
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...Seeking Alpha • Jan 21
Herbalife: Down In The Dumps, But Maybe Worth Exploring
Summary Herbalife (HLF) which offers health and wellness products across the globe has underperformed other small-caps and consumer staple stocks, while witnessing almost a 50% contraction in price over the past year. The new Chief Strategy Officer has helped revive new distributor growth after years of decline, but sales growth remains stagnant, and the outlook on the topline doesn't look too alluring. While the topline is not at full tilt, HLF's restructuring efforts are leading to a great deal of savings ($130m of aggregate savings through 2025) resulting in decent EBITDA growth. The stock is attractively priced at 4x EBITDA and an FCF yield of 27%. HLF is yet to show signs of bottom formation, although the risk-reward equation within its long-term descending channel looks favorable. Read the full article on Seeking AlphaArtículo de análisis • Nov 12
Investors Still Aren't Entirely Convinced By Herbalife Ltd.'s (NYSE:HLF) Earnings Despite 27% Price Jump
Herbalife Ltd. ( NYSE:HLF ) shares have had a really impressive month, gaining 27% after a shaky period beforehand. Not...Artículo de análisis • Nov 06
We Think You Can Look Beyond Herbalife's (NYSE:HLF) Lackluster Earnings
Herbalife Ltd.'s ( NYSE:HLF ) stock was strong despite it releasing a soft earnings report last week. However, we think...Seeking Alpha • Nov 05
Herbalife: A Top Short Squeeze Idea, Turning Higher In Price
Summary Herbalife is trading near a 20-year low valuation in October 2024. Earnings have beaten expectations for 3 consecutive quarters and are projected to grow by 20% annually in 2025-26. A large short interest position may be stuck, meaning any covering (buying shares) will push the share price straight up. Something of a price breakout has appeared on the daily chart pattern over the past week. Read the full article on Seeking AlphaArtículo de análisis • Nov 01
What Does Herbalife Ltd.'s (NYSE:HLF) Share Price Indicate?
Herbalife Ltd. ( NYSE:HLF ), is not the largest company out there, but it saw a decent share price growth of 12% on the...Seeking Alpha • Oct 03
Herbalife: The Biggest Value Trap Of The Moment
Summary Herbalife's products lack scientific backing, are highly processed, and fail to improve consumer health, leading to stalled growth and brand credibility issues. The MLM business model does not convince the market, undermining the long-term trust and credibility of the brand, despite appearing undervalued based on valuation multiples. Without drastic changes in product quality and business model, Herbalife is likely to face a gradual decline, as evidenced by stagnant financial performance. Read the full article on Seeking AlphaPrevisiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 5,597 | N/A | N/A | N/A | 1 |
| 12/31/2027 | 5,426 | 311 | N/A | 462 | 4 |
| 12/31/2026 | 5,249 | 246 | N/A | 414 | 4 |
| 3/31/2026 | 5,133 | 240 | 374 | 447 | N/A |
| 12/31/2025 | 5,038 | 228 | 253 | 333 | N/A |
| 9/30/2025 | 4,962 | 321 | 217 | 305 | N/A |
| 6/30/2025 | 4,929 | 325 | 171 | 265 | N/A |
| 3/31/2025 | 4,951 | 280 | 164 | 272 | N/A |
| 12/31/2024 | 4,993 | 254 | 163 | 285 | N/A |
| 9/30/2024 | 5,001 | 87 | 180 | 312 | N/A |
| 6/30/2024 | 5,042 | 82 | 156 | 292 | N/A |
| 3/31/2024 | 5,075 | 137 | 188 | 325 | N/A |
| 12/31/2023 | 5,062 | 142 | 223 | 358 | N/A |
| 9/30/2023 | 5,028 | 186 | 173 | 315 | N/A |
| 6/30/2023 | 5,042 | 226 | 156 | 305 | N/A |
| 3/31/2023 | 5,121 | 252 | 123 | 268 | N/A |
| 12/31/2022 | 5,204 | 321 | 196 | 353 | N/A |
| 9/30/2022 | 5,342 | 305 | 224 | 384 | N/A |
| 6/30/2022 | 5,477 | 340 | 244 | 403 | N/A |
| 3/31/2022 | 5,637 | 398 | 321 | 481 | N/A |
| 12/31/2021 | 5,803 | 447 | 309 | 460 | N/A |
| 9/30/2021 | 5,896 | 483 | 347 | 487 | N/A |
| 6/30/2021 | 5,986 | 504 | 400 | 531 | N/A |
| 3/31/2021 | 5,781 | 474 | 476 | 597 | N/A |
| 12/31/2020 | 5,542 | 373 | 517 | 629 | N/A |
| 9/30/2020 | 5,351 | 356 | 571 | 673 | N/A |
| 6/30/2020 | 5,074 | 299 | 624 | 728 | N/A |
| 3/31/2020 | 4,967 | 260 | 457 | 561 | N/A |
| 12/31/2019 | 4,877 | 311 | N/A | 458 | N/A |
| 9/30/2019 | 4,843 | 303 | N/A | 440 | N/A |
| 6/30/2019 | 4,842 | 293 | N/A | 418 | N/A |
| 3/31/2019 | 4,887 | 311 | N/A | 531 | N/A |
| 12/31/2018 | 4,892 | 297 | N/A | 648 | N/A |
| 9/30/2018 | 4,799 | 184 | N/A | 696 | N/A |
| 6/30/2018 | 4,641 | 168 | N/A | 659 | N/A |
| 3/31/2018 | 4,503 | 211 | N/A | 572 | N/A |
| 12/31/2017 | 4,428 | 214 | N/A | 591 | N/A |
| 9/30/2017 | 4,379 | 377 | N/A | 522 | N/A |
| 6/30/2017 | 4,416 | 410 | N/A | 276 | N/A |
| 3/31/2017 | 4,471 | 249 | N/A | 402 | N/A |
| 12/31/2016 | 4,488 | 260 | N/A | 367 | N/A |
| 9/30/2016 | 4,542 | 245 | N/A | 385 | N/A |
| 6/30/2016 | 4,523 | 251 | N/A | 638 | N/A |
| 3/31/2016 | 4,483 | 357 | N/A | 609 | N/A |
| 12/31/2015 | 4,469 | 339 | N/A | 629 | N/A |
| 9/30/2015 | 4,504 | 358 | N/A | 555 | N/A |
| 6/30/2015 | 4,658 | 276 | N/A | 523 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (15.8% al año) de HLF es superior a la tasa de ahorro (3.5%).
Beneficios vs. Mercado: Se prevé que los beneficios (15.8% al año) de HLF crezcan menos que el mercado US (16.8% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de HLF crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (3.2% al año) de HLF crezcan más despacio que el mercado de US (11.7% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 3.2% al año) de HLF crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de HLF sea muy elevada dentro de 3 años (1731.4%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/22 13:38 |
| Precio de las acciones al final del día | 2026/05/22 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Herbalife Ltd. está cubierta por 16 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| John Staszak | Argus Research Company |
| Meredith Adler | Barclays |
| Brian Wang | Barclays |